Evidence map›Paper›PMID 22117051›Full record

ArticleBlood2012

Transfusion-related acute lung injury: incidence and risk factors.

Pearl Toy, Ognjen Gajic, Peter Bacchetti, Mark R Looney, Michael A Gropper, Rolf Hubmayr, Clifford A Lowell, Philip J Norris, Edward L Murphy, Richard B Weiskopf and 13 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Blood, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04153487 (Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung Injury), which is not on this map. Cited by 181 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
181citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04153487 phase2completednot on this mapstarted 2019, after this paper: background citation

Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung Injury

TypeinterventionalSponsorDamanhour UniversityRan2019 to 2021Enrolled40ConditionsAcute Lung Injury, Transfusion RelatedArmsAscorbic Acid Injectable Product, Placebo
3 · Its place in the literature

Who cites it

181 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Research Priorities for Plasma and Platelet Transfusion Strategies in Critically Ill Children: From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2022
    Pooled it
  3. Transfusion thresholds for guiding red blood cell transfusion.The Cochrane database of systematic reviews · 2021
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Review
  16. Vancomycin Protects Against Lung Injury and Promotes Butyrate Metabolism.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  17. Article
  18. Review
  19. Mouse Models of Transfusion-Related Acute Lung Injury (TRALI).Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  20. Article

121 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Pearl ToyDepartment of Laboratory Medicine, Box 0451, University of California–San Francisco, San Francisco, CA 94143-0451, USA. pearl.toy@ucsf.edu
Ognjen Gajic
Peter Bacchetti
Mark R Looney
Michael A Gropper
Rolf Hubmayr
Clifford A Lowell
Philip J Norris
Edward L Murphy
Richard B Weiskopf
Gregory Wilson
Monique Koenigsberg
Deanna Lee
Randy Schuller
Ping Wu
Barbara Grimes
Manish J Gandhi
Jeffrey L Winters
David Mair
Nora Hirschler
Rosa Sanchez Rosen
Michael A Matthay
TRALI Study Group

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Transfusion-Related Acute Lung Injury: Incidence and MechanismsP50HL081027 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TOY, PEARL T · 2005 to 2009
$12.4M
Platelet and megakaryocyte biology in the normal and injured lungR01HL107386 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOONEY, MARK ROBERTS · 2011 to 2020
$4.2M
Resolution of Clinical Lung InjuryR37HL051856 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHAY, MICHAEL A. · 2006 to 2015
$3.9M
NCRR NIH HHS UL1 RR024131NHLBI NIH HHS P50 HL081027NHLBI NIH HHS P50HL081027NHLBI NIH HHS R01 HL107386NHLBI NIH HHS R37 HL051856
6 · The paper itself

Abstract

Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related mortality. To determine TRALI incidence by prospective, active surveillance and to identify risk factors by a case-control study, 2 academic medical centers enrolled 89 cases and 164 transfused controls. Recipient risk factors identified by multivariate analysis were higher IL-8 levels, liver surgery, chronic alcohol abuse, shock, higher peak airway pressure while being mechanically ventilated, current smoking, and positive fluid balance. Transfusion risk factors were receipt of plasma or whole blood from female donors (odds ratio = 4.5, 95% confidence interval [CI], 1.85-11.2, P = .001), volume of HLA class II antibody with normalized background ratio more than 27.5 (OR = 1.92/100 mL, 95% CI, 1.08-3.4, P = .03), and volume of anti-human neutrophil antigen positive by granulocyte immunofluoresence test (OR = 1.71/100 mL, 95% CI, 1.18-2.5, P = .004). Little or no risk was associated with older red blood cell units, noncognate or weak cognate class II antibody, or class I antibody. Reduced transfusion of plasma from female donors was concurrent with reduced TRALI incidence: 2.57 (95% CI, 1.72-3.86) in 2006 versus 0.81 (95% CI, 0.44-1.49) in 2009 per 10 000 transfused units (P = .002). The identified risk factors provide potential targets for reducing residual TRALI.

Indexed as

Transfusion ReactionAcademic Medical CentersAcute Lung InjuryAdultAgedBlood TransfusionCase-Control StudiesFemaleHumansIncidenceMaleMiddle AgedPopulation SurveillanceRetrospective StudiesRisk FactorsYoung Adult

Identifiers

PMID22117051
PMCPMC3286351

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.